BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 7730621)

  • 1. Requirement for peptide in alloreactive CD4+ T cell recognition of class II MHC molecules.
    Weber DA; Terrell NK; Zhang Y; Strindberg G; Martin J; Rudensky A; Braunstein NS
    J Immunol; 1995 May; 154(10):5153-64. PubMed ID: 7730621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isotypic residues in the membrane proximal domain of MHC class II beta-chains control activation of CD4+ T cells.
    Sant AJ
    J Immunol; 1993 Jun; 150(12):5299-310. PubMed ID: 8099935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptides corresponding to CD4-interacting regions of murine MHC class II molecules modulate immune responses of CD4+ T lymphocytes in vitro and in vivo.
    Shen X; Hu B; McPhie P; Wu X; Fox A; Germain RN; König R
    J Immunol; 1996 Jul; 157(1):87-100. PubMed ID: 8683160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of endogenous peptides in murine allogenic cytotoxic T cell responses assessed using transfectants of the antigen-processing mutant 174xCEM.T2.
    Crumpacker DB; Alexander J; Cresswell P; Engelhard VH
    J Immunol; 1992 May; 148(10):3004-11. PubMed ID: 1374446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unexpected reactivities of T cells selected by a single MHC-peptide ligand.
    Singh N; Van Kaer L
    J Immunol; 1999 Oct; 163(7):3583-91. PubMed ID: 10490950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD4+ T cells mature in the absence of MHC class I and class II expression in Ly-6A.2 transgenic mice.
    Henderson SC; Berezovskaya A; English A; Palliser D; Rock KL; Bamezai A
    J Immunol; 1998 Jul; 161(1):175-82. PubMed ID: 9647222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DR alpha beta dimers released from complexes with invariant chain fail to stimulate alloreactive T cell clones.
    Demotz S
    Eur J Immunol; 1993 Sep; 23(9):2100-8. PubMed ID: 8370392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rejection of K1735 murine melanoma in syngeneic hosts requires expression of MHC class I antigens and either class II antigens or IL-2.
    Chen PW; Ananthaswamy HN
    J Immunol; 1993 Jul; 151(1):244-55. PubMed ID: 8326126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viral peptide specific induction of MHC class II expression by murine T cell clones.
    Thomas DB; Smith CA; Graham CM
    J Immunol; 1996 Sep; 157(6):2386-94. PubMed ID: 8805637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T cell responses specific for subregions of allogeneic MHC molecules.
    Berkowitz N; Braunstein NS
    J Immunol; 1992 Jan; 148(2):309-17. PubMed ID: 1729357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo evidence for high frequency of I-Ab-reactive CD4+ T cells in HLA-DQ or HLA-DRA transgenic mice lacking endogenous MHC class I and/or class II expression.
    Ishimoto T; Yamamoto K; Fukui Y; Fukuda Y; Dohi K; Sasazuki T
    J Immunol; 1997 Oct; 159(8):3717-22. PubMed ID: 9378957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of memory CD4 T cell adhesion by CD4-MHC class II interaction.
    Metz DP; Farber DL; Konig R; Bottomly K
    J Immunol; 1997 Sep; 159(6):2567-73. PubMed ID: 9300674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantigen-independent deletion of diabetogenic CD4+ thymocytes by protective MHC class II molecules.
    Schmidt D; Amrani A; Verdaguer J; Bou S; Santamaria P
    J Immunol; 1999 Apr; 162(8):4627-36. PubMed ID: 10202002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of bispecific heteroconjugated antibodies (anti-T cell antigen receptor x anti-MHC class II) to study activation of T cells with a full length or truncated antigen receptor zeta-chain.
    Wu S; Yang Y; Sadegh-Nasseri S; Ashwell JD
    J Immunol; 1993 Mar; 150(6):2211-21. PubMed ID: 8450208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4+ class I-restricted T cells specific for HIV gp160 315-329.
    Moore RL; Fox BS
    Cell Immunol; 1994 Mar; 154(1):43-53. PubMed ID: 7907008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the role of MHC class II presentation in the stimulation of cytotoxic T lymphocytes by antigens targeted into the exogenous antigen-MHC class I presentation pathway.
    Rock KL; Clark K
    J Immunol; 1996 May; 156(10):3721-6. PubMed ID: 8621907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The I-Ab-restricted alloresponse of D10.G4.1 T cells is based on the recognition of an endogenous peptide.
    Gradehandt G; Kleber N; Mattner F; Milbradt S; Rüde E
    Immunology; 1993 Apr; 78(4):592-9. PubMed ID: 8495978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of class II molecules in Mls 1a recognition by CD4+ T cells is independent of the CD4 molecule.
    Borrero H; Collazo L; Macphail S
    Cell Immunol; 1993 Dec; 152(2):594-604. PubMed ID: 7903065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell receptor recognition of MHC class II alloantigens is highly cell type dependent.
    Katz JF; Sant AJ
    J Immunol; 1994 Feb; 152(4):1629-40. PubMed ID: 7907104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of antigen presentation and class II expression by a class II-associated invariant chain peptide.
    Zechel MA; Chaturvedi P; Lee-Chan EC; Rider BJ; Singh B
    J Immunol; 1996 Jun; 156(11):4232-9. PubMed ID: 8666792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.